Mani Foroohar

Mani Foroohar

Analyst-Equity bij
Leerink Partners LLC
Finance
Consumer Services

Profiel

Dr. Mani Foroohar is a Senior Managing Director of Genetic Medicines at Leerink Partners LLC.
He is also a Senior Research Analyst within the Therapeutics team focusing on Genetic Medicines.
Dr. Foroohar joins Leerink from Aptigon Capital, a Citadel Company, where he most recently was a Therapeutics Analyst focused on U.S.
and EU biotechnology, major pharmaceuticals and specialty pharmaceuticals sectors.
Prior to Aptigon, he was an Analyst at Green Owl Capital Management and an Assistant Vice President of Equity Research at Barclays.
In 2013, he co-founded Cellanyx Diagnostics, a company developing a proprietary live tumor cell, phenotypic platform for precision risk stratification in cancer to inform clinical treatment decision making.
Dr. Foroohar holds an M.D.
from Stanford, where he was a Howard Hughes Medical Institute Research Fellow in the Department of Genetics, M.B.A. from Columbia, and a B.S.
from UCLA.

Actieve functies van Mani Foroohar

BedrijvenFunctieBegin
Analyst-Equity 01-05-2018

Eerdere bekende functies van Mani Foroohar

BedrijvenFunctieEinde
Analyst-Equity 01-12-2014
Analyst-Equity -
Ervaring van Mani Foroohar in detail bekijken

Opleiding van Mani Foroohar

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

99

Eerstegraads connecties

6

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit6

Finance

Finance

Consumer Services

Finance

Consumer Services

Consumer Services

  1. Beurs
  2. Insiders
  3. Mani Foroohar